- Preview Available
- Scholarly Journal
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
Nature Communications; London Vol. 15, Iss. 1, (2024): 1583.
DOI:10.1038/s41467-024-45854-3
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.